Key result
Advanced imaging with STE and CMR detects subclinical myocardial damage in COVID-19.
Why the study?
Cardiac involvement in COVID-19 presents heterogeneously and conventional echocardiography may be silent, necessitating advanced imaging to document alterations and determine if a specific SARS-CoV-2 cardiac disease exists.
What is the diagnostic and prognostic role of different cardiac imaging techniques in evaluating COVID-19-related cardiomyopathy?
What is the diagnostic and prognostic role of different cardiac imaging techniques in evaluating COVID-19-related cardiomyopathy?
Advanced imaging modalities like CMR and STE provide essential diagnostic and prognostic insights for detecting subclinical myocardial injury in COVID-19 beyond what conventional echocardiography can offer.
Advanced imaging may detect subclinical COVID-19 myocardial injury missed by conventional echo; leaves open its role in prognosis and management.
Cardiac involvement has been described during the course of SARS-CoV-2 disease (COVID-19), with different manifestations. Several series have reported only increased cardiac troponin without ventricular dysfunction, others the acute development of left or right ventricular dysfunction, and others myocarditis. Ventricular dysfunction can be of varying degrees and may recover completely in some cases. Generally, conventional echocardiography is used as a first approach to evaluate cardiac dysfunction in patients with COVID-19, but, in some cases, this approach may be silent and more advanced cardiac imaging techniques, such as myocardial strain imaging or cardiac magnetic resonance, are necessary to document alterations in cardiac structure or function. In this review we sought to discuss the information provided by different cardiac imaging techniques in patients with COVID-19, both in the acute phase of the disease and after discharge from hospital, and their diagnostic and prognostic role. We also aimed at verifying whether a specific form of cardiac disease due to the SARS-CoV-2 can be identified.
No takes yet. Share an insight, caveat, or question.
Cecchetto et al. (2022) conducted a review in COVID-19-Related Cardiomyopathy. Cardiac imaging (Echocardiography and Cardiac Magnetic Resonance) was evaluated. Advanced cardiac imaging techniques, including speckle tracking echocardiography and CMR, are essential to identify subclinical myocardial damage and its etiology in patients with COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: